Half-yearly Report
Embargoed Release: 07:00hrs Thursday 6th September 2007
SOPHEON PLC
("Sopheon" or the "Group")
RESULTS FOR THE 6 MONTHS TO 30 JUNE 2007
BUSINESS REVIEW AND OUTLOOK
Sopheon plc ("Sopheon") the international provider of software and services
that improve the return from innovation and product development investments,
announces its unaudited interim results for the six months ended 30 June 2007
together with a business review and outlook.
Highlights:
* Revenue: £3.1m (2006: £3.0m)
Loss for the period: £0.1m (2006: loss £0.2m)
EBITDA: £0.1m (2006: loss £0.0m)
* Completed twenty-one Accolade license transactions including extension
activity, compared to twelve during the same period a year earlier. A
weaker dollar and a very large order booked in first half of 2006 affect
comparison year to year.
* Extended solution footprint by acquiring Alignent, the industry's leading
provider of strategic product planning and roadmapping software, and gained
additional opportunities for market penetration when named the preferred
transition partner to IDe, a competitor that terminated its business
activities.
* AMR Research projected that the product portfolio management (PPM) market
in which Accolade system competes will expand at a compounded annual rate
of 15% through 2011. Analysis noted that PPM is the fastest growing segment
of the product life cycle management market.
* Introduced enhancements to Accolade system, which include enabling
companies with product portfolios comprised of thousands of projects to
generate analytical reports five to ten times faster than was previously
possible.
*
Sopheon's Chairman, Barry Mence said:
"Sopheon is fortunate to be in a position of strength as we face new and unique
market opportunities. That said, we are very aware of the need to maintain
focus on organic growth and achieving high customer satisfaction, while engaged
in core integration activities resulting from our recent M&A activity."
For further information contact:
Barry Mence, Chairman Sopheon plc Tel : + 44 (0) 1483 685 735
Arif Karimjee, CFO
David Newton, Seymour Pierce Limited Tel: +44 (0) 207 107 8000
Nominated Adviser
Andrew Tan Hansard Group Tel : + 44 (0) 207 245 1100
+ 44 (0) 7957 203 685
Floor van Maaren Citigate First Financial Tel : + 31 (0) 205 754 010
About Sopheon
Sopheon (LSE: SPE) is an international provider of software and services that
help organizations improve the business impact of product innovation. The
Sopheon Accolade® product innovation process and portfolio management system
automates gate- or phase-based product development processes and provides
strategic decision support that allows companies to increase revenue and
profits from new products. Sopheon is listed on the AIM Market of the London
Stock Exchange and on the Euronext in the Netherlands. For more information,
please visit www.sopheon.com.
CHAIRMAN'S STATEMENT
Financial
Consolidated revenues for the period amounted to £3.1 million (2006: £3.0
million). Of the total revenues reported in the period, the ratio between
license, maintenance and services was 9:7:9, which is broadly consistent with
the business mix for the year 2006. Sales activity levels during the first half
of 2007 were considerably higher than in previous years; twenty-one license
transactions were completed, compared to twelve during the same period a year
earlier. There were two primary reasons that revenue growth did not reflect the
increase in sales transactions. First, results were affected by a substantial
decline in the value of the US dollar. Second, as we have noted previously,
revenue performance in a particular period can vary depending on the timing of
individual transactions; in the first half of 2006, our European business
closed the largest sale in the history of the Group. No singularly large sales
were closed during the first half of 2007.
Gross margin, which is arrived at after charging direct costs such as payroll
for client services staff, was 72% for the period, again consistent with the
performance in the year 2006 but down from the 76% recorded in the first half
of 2006 which was enhanced by the large license sale referred to above. Also,
our ongoing margins continue to be impacted by the involvement partners have in
delivering certain services assignments and we expect this to continue for the
foreseeable future. We actively encourage partner involvement as part of our
business strategy to grow awareness of and deployment capability for Sopheon
solutions around the world.
Tight cost controls, the weaker dollar and higher levels of R&D capitalization
as set out in note 5 have resulted in overheads falling to approximately £2.3
million (2006: £2.5 million). As a consequence the loss for the period improved
to £0.1 million (2006: £0.2 million). The loss includes interest, depreciation
and amortisation costs amounting to approximately £0.2 million (2006: £0.2
million). The EBITDA result, which does not include these elements, was £82,000
(2006: £27,000 loss).
Trading
During the first half of 2007 we gained eight new license customers and closed
thirteen license extension orders, in addition to a number of consultancy and
services contracts. Repeat orders from the customer base continue to increase
in number, as well as in value to our business; ninety-six companies throughout
the world now license our software and many continue to buy additional products
and services from us. We expect to break through the milestone threshold of one
hundred licensees for Sopheon software in the current quarter. This total does
not include new customers added through the acquisition of Alignent, which has
of course taken us above 100.
The level of activity in our US business suggests that the Group is entering a
new, intense stage of growth. In order to help accelerate this transition and
ensure effective management of the associated expansion, we have taken steps to
fortify our senior-management team. During the second quarter we added
executive leaders for our North American sales and client services
organizations. Each brings considerable experience from Lawson Software and
Oracle respectively.
As further described below, the acquisition of Alignent closed on 21 June 2007.
Including Alignent, full-year revenue visibility incorporating booked revenue,
contracted services business and the run rate of maintenance contracts, stood
at approximately £4.9m at the mid year point. We will update this information
in our next trading update to shareholders scheduled for 25 October 2007.
Corporate
On 11 June 2007 Sopheon announced the acquisition of Alignent Software Inc
("Alignent"). Further details of the acquisition are set out in the notes to
this statement. Based in California, USA, Alignent is one of only a few
suppliers worldwide that specializes in the provision of strategic product and
technology roadmapping software for complex global companies. Alignent's
flagship offering, Vision Strategist, is generally recognized as the leading
application of its kind in the marketplace. The software has a proven track
record of helping large organizations improve strategic product planning. The
acquisition of Alignent will help to drive expansion of Sopheon's business in
two areas. First, for the company's nearly 100 existing clients in chemical and
consumer packaged goods markets, it will extend Sopheon's solution to include
strategic product planning. Secondly, Alignent's roster of industry-leading
customers will give Sopheon instant credibility in a range of new markets such
as aerospace, defense and high-tech manufacturing, helping to accelerate
Sopheon's entry into these industry areas. Sopheon expects the Alignent
business to make a positive EBITDA contribution from the first year following
the acquisition.
On 13 August Sopheon announced that it had entered into an agreement with
Integrated Development Enterprise, Inc. ("IDe") under which Sopheon was to
offer transition services and support to IDe customers previously covered by
IDe maintenance and support contracts. The agreement followed a decision by
IDe, a former competitor of Sopheon, to discontinue its business. Terms of the
agreement afford Sopheon exclusive access to such IDe assets as its customer
list, software code and documentation, but Sopheon is not committed to assume
any of IDe's obligations. The terms and conditions of any customer transition
will be as agreed between Sopheon and the particular customer and could include
transitioning to Sopheon's Accolade software and services. IDe's client base of
18 companies is approximately one-fifth the size of Sopheon's and similarly
includes many Fortune 1000 businesses. Sopheon is engaged in discussions with
several of these companies and indications are positive that a number will make
the decision to switch to Accolade.
Market & Product
The market outlook for product life cycle management (PLM) applications remains
strong. Analysts are forecasting compound annual growth rates ranging from 9%
to 14% from 2007 through 2011. Expectations for the product portfolio
management (PPM) submarket in which Sopheon's Accolade software system is
classified are particularly high. An August 2007 report from IT advisory firm
AMR Research noted that product portfolio management is the fastest-growing
segment of PLM, and projected that it will continue to grow at a compounded
annual rate of 15% through 2011. AMR attributes this expansion to increasing
recognition among manufacturers that the decision support provided by solutions
such as Sopheon's Accolade is needed for new product success.
We continue to make important progress in the evolution of Accolade's
capabilities. In May we introduced enhancements that included a substantial
increase in the power of the system's portfolio engine. The latter improvement
was specifically designed to help Fortune1000 companies that are managing
complex portfolios encompassing thousands of projects. It enables such users to
generate analytical reports five to ten times faster than was previously
possible. Other changes to the software were aimed at strengthening
project-related communication among product development decision-makers and
team members, and at furthering Accolade's ease-of-use, an attribute area in
which the Sopheon system is already recognized as leading the industry. These
enhancements were principally driven by feedback from current Accolade users,
including our recently formed Product Advisory Council. Existing clients were
particularly enthusiastic in their reaction to the improved capabilities.
Evidence is growing of the significant business opportunities surrounding our
acquisition of Alignent and its strategic product planning and roadmapping
solution, Vision Strategist. Since completing the merger transaction in late
June, we have signed two new Vision Strategist clients. We have also had
communication with principal decision-makers and process owners at a
cross-section of Alignent's existing accounts, including Boeing, BAE Systems,
Corning, Lockheed Martin and Motorola. A number of key renewals have been
signed, demonstrating that Vision Strategist users continue to see value in the
solution. On August 30th we convened a virtual meeting of the Alignent client
base during which we shared our plans for further development of Vision
Strategist, including its integration with Accolade.
We have also begun aggressively pursuing new business in the aerospace and
defense markets, an effort that has included adding a person experienced in
this sector to our direct sales team. He will focus on the sale of both Vision
Strategist and Accolade to these new markets.
Sopheon is receiving consistent, positive affirmation from business analysts
and other independent thought leaders concerning its decision to expand into
the strategic product planning and roadmapping market. This reinforcement has
been complemented by endorsements of the newly acquired Vision Strategist
product offering. An article in the May issue of Research Technology Management
magazine by a foremost authority on enterprise strategic and technology
planning characterized Vision Strategist as the only commercially available
tool that comes close "to meeting all the unique requirements" of real-time
technology roadmapping,
We have previously acknowledged the importance of partnerships to achieving our
goals for market expansion. While our reseller network continues to struggle
for traction, a number of consulting partners are now showing interest in
supporting Sopheon in its strategic efforts to migrate clients previously
served by Alignent and IDe.
Outlook
We would clearly prefer to be reporting a larger period-to-period increase in
revenues. However, the fact that we were able to achieve similar revenue
performance as 2006, in spite of the weaker dollar and the lack of a singularly
large sale closing during the first half of 2007, is in our view a key sign of
growing maturity of the business. Our bottom line performance continues to
improve, and our balance sheet is in good shape. Looking forward, the sales
funnel is robust, with a number of potentially large deals in the prospect
population.
Strategically Sopheon has taken an important step forward through the
acquisition of Alignent. We look forward to leveraging the substantial
opportunities for its strategic product planning solution among existing
Alignent customers, Sopheon customers, and newly identified prospects in
aerospace and defense markets. In addition, we believe that the agreement with
IDe will build on Sopheon's history of continued growth in the expanding
product portfolio and innovation process management market. In parallel with
commercial activities, we continue to invest heavily in product development.
Based on these efforts, we will introduce new versions of both Sopheon's
Accolade system and Alignent's Vision Strategist by the end of the year.
We remain confident that 2007 full-year performance will show substantial
improvement over 2006.
Barry Mence 6 September 2007
Chairman
Trademarks
Accolade® is a registered trademark of Sopheon.
Stage-Gate® is a registered trademark of the Product Development Institute.
CONSOLIDATED INCOME STATEMENT FOR THE SIX MONTHSENDED
30 JUNE 2007(UNAUDITED)
2007 2006
£'000 £'000
Revenue 3,062 2,954
Cost of sales (851) (709)
Gross profit 2,210 2,245
Administrative, research and development, and 2,288 2,486
distribution expenses
Operating loss (78) (241)
Finance revenue 20 19
Finance costs (15) (24)
Loss before and after taxation (73) (246)
Loss for the period (73) (246)
(all attributable to members of the parent company)
Loss per share - basic and diluted (pence) (0.1p) (0.2p)
EBITDA 82 (27)
CONSOLIDATED STATEMENT OF RECOGNISED INCOME AND EXPENSE
FOR THE SIX MONTHS ENDED 30 JUNE 2007(UNAUDITED)
2007 2006
£'000 £'000
Exchange difference on translation of foreign (10) (76)
operations
Net income/(expense) recognized directly in equity (10) (76)
Loss for the financial period (73) (246)
Total recognized income and expense for the period (83) (322)
(all attributable to members of the parent company)
CONSOLIDATED BALANCE SHEET AT 30 JUNE 2007 (UNAUDITED)
2007 2006
£'000 £'000
Assets
Non-current assets
Property, plant and equipment 184 109
Goodwill and intangible assets 3,552 792
Non-current receivables 10 10
3,746 911
Current assets
Trade and other receivables 2,170 1,961
Cash and cash equivalents 2,393 1,537
4,563 3,498
Total assets 8,309 4,409
Liabilities
Current liabilities
Bank loans 324 94
Trade and other payables 2,941 2,621
3,265 2,715
Non-current liabilities
Bank loans 1,445 -
Total liabilities 4,710 2,715
Net assets 3,599 1,694
Equity and reserves
Share capital 7,279 6,674
Other reserves 74,289 72,986
Retained losses and translation reserve (77,969) (77,966)
Total equity (all attributable to members of the 3,599 1,694
parent company)
CONSOLIDATED CASH FLOW STATEMENT FOR THE SIX MONTHS ENDED
30 JUNE 2007(UNAUDITED)
2007 2006
£'000 £'000
Operating Activities: loss before and after taxation (73) (246)
Adjustments for non-cash and financial items 201 237
Movements in working capital 174 136
Interest paid (15) (24)
Net cash from operating activities 286 103
Investing activities (2,294) (285)
Financing activities 3,369 (251)
Net (decrease)/increase in cash and cash equivalents 1,361 (433)
NOTES
1. Principal Accounting Policies
Basis of preparation
The interim financial information for all periods has been prepared on a basis
consistent with the recognition and measurement principles of International
Financial Reporting Standards ("IFRS") and Interpretations issued by the
International Accounting Standards Board as adopted by the European Union, and
those parts of the Companies Act 1985 which apply to companies preparing their
financial statements under IFRS. The six month figures to 30 June 2007 and 30
June 2006 are un-audited and do not constitute statutory accounts within the
meaning of Section 240 of the Companies Act 1985. The principal accounting
policies are set out below and are expected to be applied for the full year.
There is a possibility that the directors may determine that some changes to
those policies are required when preparing the full annual financial
statements, since the IFRS and IFRIC interpretations that will be applicable
and adopted for use in the European Union at 31 December 2007 are not known
with certainty at the time of preparing this interim financial information. The
policies have been applied consistently to all the periods presented, and on
the going concern basis.
Going Concern
In the first half of 2007 the group's revenues from continuing operations was £
3.1 million and its EBITDA (earnings before interest, tax, depreciation and
amortisation) basis was £82,000.
At the period end the group reported net assets of £3.6 million and gross cash
resources of £2.4 million. The group's debts comprise a $3.5 million (£1.8
million) loan note from BlueCrest Capital Finance LLC ("BlueCrest") which was
taken in connection with the acquisition of Alignent Software Inc, as described
below. The loan bears interest at 11.03% and is repayable in equal instalments
over 48 months. The debt is supported by a guarantee and debenture from Sopheon
plc. The group also has access to a $750,000 (£380,000) bank line of credit
with BlueCrest which is secured against the trade receivables of Sopheon's
North American business. At 30 June 2007, no funds were drawn against this
facility. The facilities with BlueCrest have been in place since June 2007 and
were negotiated in conjunction with the loan note.
The directors are positive about the direction, focus and momentum of the
business and believe that this, together with the group's existing resources
provide it with adequate funding to support its activities through to the point
at which they anticipate that operations will become cash generative on a
sustained basis. This is in turn dependent on the group continuing to deliver
sales growth.
Should this not be the case, Sopheon continues to have access to the equity
markets, as demonstrated by the recent placing in London of 12 million shares
to raise £2 million after expenses. In addition, the group has access to an
equity line of credit facility from GEM Global Yield Fund Limited ("GEM") for
an aggregate of €10 million for a term expiring in December 2007. GEM's
obligation to subscribe for shares is subject to certain conditions linked to
the prevailing trading volumes and prices of Sopheon shares on the Euronext
stock exchange. To date Sopheon has made just one call on the equity line of
credit facility, raising just under €1 million in March 2004, leaving €9
million available. The directors are considering whether it is appropriate to
seek an extension to the life of the instrument in order to provide continued
access to the facility.
While there are uncertainties as to the achievement of the expected sales
growth and the continued availability of facilities, the directors believe that
together, the factors described above enable the group to continue as a going
concern for the foreseeable future. The financial information does not include
the adjustments that would be required if the company or group were unable to
continue as a going concern.
Basis of consolidation
The consolidated financial statements incorporate the financial statements of
the Company and entities controlled by the Company ("subsidiaries"). Control is
achieved where the Company has the power to govern the financial and operating
policies of an entity and to obtain benefits from its activities. All
intra-group transactions, balances, income and expenses are eliminated on
consolidation.
Business combinations
Goodwill on acquisition is initially measured at cost being the excess of the
cost of the business combination over the group's interest in the net fair
value of the identifiable assets, liabilities and contingent liabilities. The
fair value of the consideration is determined by applying appropriate discounts
to contingent and deferred consideration, to the level where the Group
considers those liabilities will be payable. Following initial recognition,
goodwill is not amortised but is measured at cost less any accumulated
impairment losses. Goodwill is reviewed for impairment annually, or more
frequently if events or changes in circumstances indicate that the carrying
value may be impaired.
Identifiable intangible assets are capitalised at fair value as at the date of
acquisition. The useful lives of these intangible assets are assessed and
amortisation is charged on a straight line basis, with the expense taken to the
income statement. Intangible assets are tested for impairment when a trigger
event occurs. Useful lives are also examined on an annual basis and
adjustments, where applicable are made on a prospective basis.
Revenue recognition
Revenue is measured at the fair value of the consideration received or
receivable and represents amounts receivable for goods and services provided in
the normal course of business, net of discounts and sales related taxes. Sales
of software products are recognised on delivery, and when no significant vendor
obligations remain. Revenues from implementation and consultancy services are
recognised as the services are performed. Revenues relating to maintenance and
post contract support agreements are deferred and recognised over the period of
the agreements. Revenues and associated costs under long term contracts are
recognised on a percentage basis as the work is completed and any relevant
milestones are met, using latest estimates to determine the expected duration
and cost of the project.
Property, plant and equipment
Computer equipment and fixtures and fittings are stated at cost less
accumulated depreciation and any accumulated impairment losses. Depreciation is
charged so as to write off the costs of assets over their estimated useful
lives, using the straight-line method. Assets held under finance leases are
depreciated over their expected useful lives on the same basis as owned assets,
or, when shorter, over the term of the relevant lease. The gain or loss arising
on the disposal or retirement of an item of property, plant and equipment is
determined as the difference between the sale proceeds and the carrying amount
of the asset and is recognised in profit or loss.
Share based payments
The group issues equity-settled share-based payments to certain employees.
Equity-settled share-based payments are measured at fair value (excluding the
effect of non-market-based vesting conditions) at the date of grant. The fair
value determined at the date of grant is expensed on a straight-line basis over
the vesting period, based on the group's estimate of the shares that will
eventually vest and adjusted for the effect of non-market-based vesting
conditions. Fair value is measured by the binomial option pricing model. The
expected life used in the model had been adjusted, based on management's best
estimate, for the effects of non-transferability, exercise restrictions and
behavioral considerations.
Research and development
In accordance with IAS 38, development expenditure on internally developed
software products is capitalised if it can be demonstrated that:
* it is technically feasible to develop the product;
* adequate resources are available to complete the development;
* there is an intention to complete and sell the product;
* the group is able to sell the product;
* sales of the product will generate future economic benefits; and
* expenditure on the product can be measured reliably
Capitalised development costs are amortised over four years. Development costs
not satisfying the above criteria, and expenditure on the research phase of
internal projects, are recognised in profit or loss as incurred.
Deferred taxation
Deferred tax is recognised on differences between the carrying amounts of
assets and liabilities in the financial statements and the corresponding tax
bases used in the computation of taxable profit, and it is accounted for using
the balance sheet liability method. Deferred tax liabilities are generally
recognised for all taxable temporary differences, but deferred tax assets are
recognised only to the extent that it is probable that taxable profits will be
available against which deductible temporary differences can be utilised.
Deferred tax is calculated at the tax rates that are expected to apply in the
period when the liability is settled or the asset realised. Deferred tax is
charged or credited to profit or loss, except when it relates to items charged
or credited directly to equity, in which case the deferred tax is also dealt
with in equity.
Treatment of foreign currencies for consolidation
For the purpose of the consolidated financial statements, the results and
financial position of each entity are expressed in sterling, which is the
functional currency of the parent company, and the presentation currency for
the consolidated financial statements. The assets and liabilities of the
Group's foreign operations (including comparatives) are expressed in sterling
using exchange rates prevailing on the relevant balance sheet date. Income and
expense items (including comparatives) are translated at the appropriate
exchange rates for the period in which the transactions occurred. Exchange
differences arising (including exchange differences on intra-group loans) are
classified as equity and transferred to the Group's translation reserve. Such
translation differences are recognized in profit or loss in the period in which
the foreign operation is disposed of.
Retirement benefit costs
Payments to defined contribution retirement benefit plans are charged as an
expense as they fall due. The group does not operate any defined benefit
retirement benefit plans.
Leasing
Assets held under finance leases are recognised as assets of the group at their
fair value at the inception of the lease or, if lower, at the net present value
of the minimum lease payments. The corresponding liability to the lessor is
included in the balance sheet as a finance lease obligation. Lease payments are
apportioned between finance charges and reduction of the lease obligation so as
to achieve a constant rate of interest on the remaining balance of the
liability. Finance charges are charged to profit or loss. Rentals payable under
operating leases are charged to profit or loss on a straight-line basis over
the term of the relevant lease.
2. Turnover
All of the group's revenue in respect of the six month periods ended 30 June
2007 and 2006 are derived from continuing operations and from the group's
single business segment, the design, development and marketing of software
products with associated implementation and consultancy services.
3. Earnings per share
The calculation of basic loss per ordinary share is based on a loss of £73,000
(2006 - £246,000), and on 134,904,994 ordinary shares (2006 - 133,350,885)
being the weighted average number of ordinary shares in issue during the year.
The loss attributable to ordinary shareholders and the weighted average number
of ordinary shares for the purpose of calculating the diluted loss per ordinary
share are identical to those used for calculating the basic loss per ordinary
share in both 2007 and 2006. This is because the exercise of share options
would have the effect of reducing the loss per ordinary share and is therefore
not dilutive.
4. Acquisition of Alignent Software Inc
£'000
Net Assets acquired
Property, plant and equipment 64
Intangible assets 2,050
Trade and other receivables 150
Cash and cash equivalents 65
Trade and other payables including deferred income (931)
1,398
Goodwill 481
Cost of acquisition 1,879
Comprising
Cash consideration 1,772
Costs of transaction 107
1,879
The acquisition completed on 21 June 2007. Cash consideration, transaction
expenses and working capital for the combined group were funded by (i) raising
£2.1 million (before expenses) through the placing of 12,000,000 Sopheon
ordinary shares at 17.5p per share and (ii) a $3.5 million loan from BlueCrest
Capital Finance LLC repayable over 48 months. Included in intangible assets is
the fair value of technology and customer relationships arising upon
acquisition, estimated at £705,000 and £1,322,000 respectively. All other
assets and liabilities are recorded at book value, which is provisionally
considered to be the same as fair value.
5. Intangible Assets
In accordance with IAS 38 Intangible Assets, certain development expenditure
must be capitalised and amortised based on detailed technical criteria, rather
than automatically charging such costs in the profit and loss account as they
arise. This has led to the capitalization of £321,000 (2005: £248,000), and
amortization of £138,000 (2005: £184,000) during the period.
6. Cautionary Statement
Sopheon has made forward-looking statements in this press release, including
statements about the market for and benefits of its products and services;
financial results; product development plans; the potential benefits of
business relationships with third parties and business strategies. These
statements about future events are subject to risks and uncertainties that
could cause Sopheon's actual results to differ materially from those that might
be inferred from the forward-looking statements. Sopheon can make no assurance
that any forward-looking statements will prove correct.
Independent review report to Sopheon plc
Introduction
We have been instructed by the company to review the financial information for
the six months ended 30 June 2007 set out on pages 1 to 10. We have read the
other information contained in the interim report and considered whether it
contains any apparent misstatements or material inconsistencies with the
financial information.
Our report has been prepared in accordance with the terms of our engagement to
assist the company in meeting their interim reporting requirements and for no
other purpose. No person is entitled to rely on this report unless such a
person is a person entitled to rely upon this report by virtue of and for the
purpose of our terms of engagement or has been expressly authorised to do so by
our prior written consent. Save as above, we do not accept responsibility for
this report to any other person or for any other purpose and we hereby
expressly disclaim any and all such liability.
Directors' responsibilities
The interim report, including the financial information contained therein, is
the responsibility of, and has been approved by the directors. The directors
are responsible for preparing the interim report in accordance with rules of
the London Stock Exchange for companies trading securities on the Alternative
Investment Market and for the rules governing securities listed on Euronext,
which require that the half-yearly report be presented and prepared in a form
consistent with that applied in preparing the preceding annual accounts except
where any changes, and the reasons for them, are disclosed. As disclosed in
note 1, the annual financial statements of the company are prepared in
accordance with International Financial Reporting Standards as adopted for use
in the EU. This interim report has been prepared in accordance with the basis
set out in note 1. The accounting policies are consistent with those that the
directors intend to use in the next annual financial statements.
Review work performed
We conducted our review in accordance with guidance contained in Bulletin 1999/
4 issued by the Auditing Practices Board for use in the United Kingdom. A
review consists principally of making enquiries of group management and
applying analytical procedures to the financial information and underlying
financial data and based thereon, assessing whether the accounting policies and
presentation have been consistently applied unless otherwise disclosed. A
review excludes audit procedures such as tests of controls and verification of
assets, liabilities and transactions. It is substantially less in scope than an
audit performed in accordance with International Standards on Auditing (UK and
Ireland) and therefore provides a lower level of assurance than an audit.
Accordingly we do not express an audit opinion on the financial information.
Review conclusion
On the basis of our review we are not aware of any material modifications that
should be made to the financial information as presented for the six months
ended 30 June 2007.
Going concern
In arriving at our review conclusion, we have considered the adequacy of the
disclosures made in Note 1 regarding the Group's ability to continue as a going
concern, including the directors' assessment of the ability of the Group to
achieve its forecasts.
BDO Stoy Hayward LLP 6 September 2007
Chartered Accountants
London